A review of head-to-head clinical trials comparing key outcomes of using GLP-1RAs (dulaglutide, exenatide BD, exenatide QW, liraglutide or lixisenatide) with those of using DPP-IV (sitagliptin), SU (glimepiride
En este caso, los medicamentos imitan la accin de las hormonas GLP-1 que se producen en el intestino delgado
Slower escalation may reduce gastrointestinal side effects and improve tolerance
GLP-1 receptor agonists are among the most effective non-insulin medications for lowering hemoglobin A1c (HbA1c) and often demonstrate a greater reduction in HbA1c compared to other classes of diabetes medications [5]
Hammond LJ, Lowdell MW, Cerrano PG, Goode AW, Bottazzo GF, Mirakian R
Nu contine gluten, aspartam si lactoza